Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Sodium chloride
Baxter Healthcare Limited
B05XA; B05XA03
Sodium chloride
0.45 percent weight/volume
Solution for infusion
Product subject to prescription which may not be renewed (A)
Electrolyte solutions; sodium chloride
Marketed
2010-07-02
PACKAGE LEAFLET: INFORMATION FOR THE USER Sodium Chloride 0.45 % Solution for Infusion Active substance: sodium chloride Read all of this leaflet carefully before you are given this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or nurse. • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. This medicine is called `Sodium Chloride 0.45% Solution for Infusion’, but will be referred to as `Sodium 0.45 Infusion’ throughout the remainder of this leaflet. What is In this leaflet: 1. What Sodium 0.45 Infusion is and what it is used for 2. What you need to know before you are given Sodium 0.45 Infusion 3. How you will be given Sodium 0.45 Infusion 4. Possible side effects 5. How to store Sodium 0.45 Infusion 6. Contents of the pack and other information. 1. What Sodium 0.45 Infusion is and what it is used for Sodium 0.45 Infusion is a solution of sodium chloride in water. Sodium chloride is a chemical substance (often called “salt”) found in the blood. Sodium 0.45 Infusion is used to treat: • a loss of body water, for example after being sick or having diarrhoea (hypertonic extracellular dehydration) • a lower than normal volume of blood in the body (hypovolaemia) Sodium 0.45 infusion may also be used to deliver or to dilute other medicines for infusion. 2. What you need to know before you are given Sodium 0.45 Infusion Do NOT receive Sodium 0.45 Infusion if you are suffering from any of the following conditions • lower levels of chloride in the blood than normal (hypochloraemia) • lower levels of sodium in the blood than normal (hyponatraemia) • severe kidney problems causing lower than normal or no urine production (oliguria or anuria) • higher than normal levels of water or sodium in the blood (fluid or sodium retention) • uncompensated heart failure. This is heart failure that is not Прочитать полный документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sodium Chloride 0.45% w/v Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Chloride: 4.5 g/l Each ml contains 4.5 mg sodium chloride. Na + Cl - mmol/l 77 77 mEq/l 77 77 154 mOsm/l (approx.) pH: 4.5 – 7.0 For the full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Solution for infusion. Clear solution, free from visible particles. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sodium Chloride 0.45% w/v Solution for Infusion is indicated for the treatment of hypertonic extracellular dehydration or hypovolaemia in cases where the intake of fluids and electrolytes by normal routes is not possible. It can also be used as a vehicle or diluent of compatible medicinal products. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults,_ older people_, Adolescents and Children: The dosage, rate and duration of administration is to be individualised as determined by several factors including age, weight, clinical condition, concomitant treatment and in particular the patient’s hydration state, clinical and laboratory response to treatment. Fluid balance and plasma electrolyte concentrations must be monitored during treatment. _Recommended dosage:_ - For adults, older people and adolescents: 500 ml to 3 litres/24h, - For babies and children: 20 to 100 ml per 24 h and per kg of body weight, depending on the age and the total body mass. The recommended dosage when used as a vehicle or diluent ranges from 50 to 250 ml per dose of medicinal product to be administered. _Administration rate:_ H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ Прочитать полный документ